- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 207/404 - 2,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
Patent holdings for IPC class C07D 207/404
Total number of patents in this class: 147
10-year publication summary
|
12
|
7
|
5
|
8
|
7
|
11
|
13
|
4
|
15
|
5
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Biogen MA Inc. | 948 |
8 |
| Cv6 Therapeutics (NI) Limited | 33 |
8 |
| Chevron Oronite Company LLC | 605 |
6 |
| Clariant International Ltd. | 892 |
6 |
| Uniwersytet Jagiellonski | 282 |
6 |
| Warszawski Uniwersytet Medyczny | 65 |
4 |
| Mint Biotechnologies Co., Ltd. | 22 |
4 |
| Advanced Accelerator Applications S.A. | 44 |
3 |
| E-Therapeutics PLC | 58 |
3 |
| Ecolab USA Inc. | 5842 |
3 |
| Sanofi | 4338 |
3 |
| Novartis AG | 10170 |
2 |
| Wyeth LLC | 600 |
2 |
| Merck Patent GmbH | 5751 |
2 |
| Bayer Cropscience AG | 1820 |
2 |
| DSM IP Assets B.V. | 5395 |
2 |
| The General Hospital Corporation | 4900 |
2 |
| Academisch Ziekenhuis Groningen | 123 |
2 |
| Canopy Growth Corporation | 210 |
2 |
| Council of Scientific & Industrial Research | 1449 |
2 |
| Other owners | 75 |